doi: 10.3389/fnins.2020.591177 Received 03 August 2020 Accepted 12 October 2020 Published 28 October 2020 Volume 14 - 2020 Edited by Paulo Henrique Rosado-de-Castro, DOr Institute for Research and Education (IDOR), Brazil Reviewed by Ming Zhang, Kunming Medical University, China
It is not a drug, food, or supplement
Tachykinin receptors antagonism for asthma: a systematic review
In models of corticosteroid-impaired muscle healing, BPC-157 completely reverses the aggravating effects of systemic corticosteroid treatment (6-methylprednisolone), restoring normal healing kinetics and full functional recovery
How Do You Know Youre Actually Getting BPC-157
Notably, the highest dose tested (54 mg) showed increased gastrointestinal event frequency compared to lower doses, suggesting a dose-relationship for this effect category